ARTICLE | Product Development
Infusion confusion: the rollout of mAbs for COVID-19 could be chaotic
Operation Warp Speed is leaving critical aspects of mAb deployment to overwhelmed state and local governments
October 24, 2020 12:42 AM UTC
FDA could soon grant emergency use authorization to one or more COVID-19 monoclonal antibodies. Rather than being celebrated for creating lifelines that could keep hundreds of thousands of Americans out of hospitals, the announcements may mark the start of yet another round of pandemic pandemonium.
Effectively deploying mAbs will require the kind of creative thinking and tight coordination across the healthcare system that have helped South Korea and other countries tame COVID-19 — and that are largely absent in the U.S...